International
The Morning Science

What science found today

‹
 

Research

NAION during incretin-based therapy: an optic nerve head still adapted to hypertension

Nature ·

The Brief

  • A Nature journal article, titled "NAION during incretin-based therapy: an optic nerve head still adapted to hypertension", was listed in a nature.com subject feed dated 2026-11-19.
  • The source provided only the title, so the article's findings beyond the title cannot be confirmed from the available material.
  • The title links non-arteritic anterior ischaemic optic neuropathy (NAION) with incretin-based therapy and describes the optic nerve head as still adapted to hypertension.

Why it matters

The title ties a serious optic nerve condition, NAION, to incretin-based therapy, which is relevant to clinicians and patients weighing that treatment's risks. The full article is needed to judge the strength of the findings.

Who’s affected

  • ophthalmologists and neurologists
  • clinicians prescribing incretin-based therapy
  • patients taking incretin-based therapy

How do you feel about this?

0 Comments

    NAION during incretin-based therapy: an optic nerve head still adapted to hypertension – The Morning Science